Impact of physical illness on quality of life and antidepressant response in geriatric major depression

Journal of the American Geriatrics Society

Volumn 44, Issue 10, 1996, Pages 1220-1225

  Small, Gary W ^a,b,g   Birkett, Martin ^c   Meyers, Barnett S ^d   Koran, Lorrin M ^e   Bystritsky, Alexander ^a   Nemeroff, Charles B ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHYSICAL DISEASE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK ASSESSMENT; TREATMENT PLANNING; WELLBEING;

EID: 0029798211     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb01373.x     Document Type: Article

References (32)

1. Koenig HG, Blazer DG. Epidemiology of geriatric affective disorders. Clin Geriatr Med 1992;8:235-251.
2. Reynolds CV, Schneider LS, Lebowitz BD et al. Treatment of depression in elderly patients: Guidelines for primary care. In: LS Schneider, CF Reynolds, BD Lebowitz, A Friedhoff, eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, DC: American Psychiatric Press, 1994, pp. 463-490.
3. Alexopoulos GS, Young RC, Meyers BS. Geriatric depression: Age of onset and dementia. Biol Psychiatry 1993;34:141-145.
4. Wells KB, Stewart A, Hays RD et al. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study. JAMA 1989;262:914-919.
5. Hays RD, Wells KB, Sherbourne CD et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 1995;52:11-19.
6. Evans ME, Copeland JRM, Dewey ME. Depression in the elderly in the community: Effect of physical illness and selected social factors. Int J Geriatr Psychiatry 1991;6:787-795.
7. Lyness JM, Caine ED, Conwell Y et al. Depressive symptoms, medical illness, and functional status in depressed psychiatric inpatients. Am J Psychiatry 1993;150:910-915.
8. Rapp SR, Parisi SA, Wallace CE. Comorbid psychiatric disorders in elderly medical patients: A 1-year prospective study. J Am Geriatr Soc 1991;39:124-131.
9. Schneider LS, Olin JT. Efficacy of acute treatment for geriatric depression. Int Psychogeriatr 1995;7:7-26.
10. Lipsey JR, Robinson RG, Pearlson GD et al. Nortriptyline treatment of post-stroke depression: A double-blind study. Lancet 1984;1:297-300.
11. Katz IR, Simpson GM, Curlik SM et al. Pharmacologic treatment of major depression for elderly patients in residential care settings. J Clin Psychiatry 1990;51(suppl):41-47.
12. Tollefson GD, Bosomworth JC, Heiligenstein JH et al. A double-blind placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. Int Psychogeriatr 1995;7:89-104.
13. Small GW, Hamilton SH, Bystritsky A et al. Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Int Psychogeriatr 1995;7:41-54.
14. Heiligenstein JH, Ware JE, Beusterien KM et al. Acute effects of fluoxetine vs. placebo on functional health and well-being in late-life depression. Int Psychogeriatr 1995;7:125-138.
15. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Third Edition-Revised (DSM-III-R). Washington, DC: American Psychiatric Association, 1987.
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
17. Folstein M, Folstein S, McHugh P. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
18. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
19. Mossey JM, Knott K, Craik R. The effects of persistent depressive symptoms on hip fracture recovery. J Gerontol 1990;45:M163-168.
20. Williamson GM, Schulz R. Physical illness and symptoms of depression among elderly outpatients. Psychol Aging 1992;7:343-351.
21. Koenig HG, O'Connor CM, Guarisco SA et al. Depressive disorder in older medical inpatients on general medicine and cardiology services at a university teaching hospital. Am J Geriatr Psychiatry 1993;1:197-210.
22. Salzman C, Schneider LS, Alexopoulos G. Treatment of depression in the elderly. In: F Bloom, D Kupfer, eds. Psychopharmacology: Fourth Generation of Progress. New York: Raven Press, 1995, pp. 1471-1477.
23. Dunner DL, Cohn JB, Walshe T et al. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry 1992;53(suppl):57-60.
24. Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994;164:665-673.
25. Popkin, MK, Callies AL, Mackenzie TB. The outcome of antidepressant use in the medically ill. Arch Gen Psychiatry 1985;42:1160-1163.
26. Koenig HG, Veeraindar G, Shelp F et al. Major depression in hospitalized medically ill older men: Documentation, management, and outcome. Int J Geriatr Psychiatry 1992;7:25-34.
27. Hughes DC, DeMallie D, Blazer DG. Does age make a difference in the effects of physical health and social support on the outcome of major depressive episode? Am J Psychiatry 1993;150:728-733.
28. Kennedy GJ, Kelman HR, Thomas C. Persistence and remission of depressive symptoms in late life. Am J Psychiatry 1991;148:174-178.
29. Cole MG. The prognosis of depression in the elderly. Can Med Assoc J 1990;143:633-639.
30. Henrichsen GA, Hernandez NA. Factors associated with recovery from and relapse into major depressive disorder in the elderly. Am J Psychiatry 1993;150:1820-1825.
31. Small GW, Schneider LS, Holman SL et al. Site variability in a multisite geriatric depression trial. Int J Geriatr Psychiatry, in press.
32. DeVane CL. Pharmacogenetics and drug metabolism of newer antidepressant agents. J Clin Psychiatry 1994;55 (suppl):38-45.